Name: Monopar Therapeutics Inc. (MNPR) Balance Sheet
Creator: FinSpry

Monopar Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Monopar Therapeutics Inc. (MNPR) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	45.82	7.27	8.19	20.30	16.74	13.21
Short-Term Investments	14.40	0.00	4.93	0.00	0.00	0.00
Cash & Short-Term Investments	60.21	7.27	8.19	20.30	16.74	13.21
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.08	0.07	0.05	0.22	0.06	0.02
Total Current Assets	60.29	7.33	13.17	20.52	16.80	13.23
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.01	0.06	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.07	0.12
Total Non-Current Assets	0.00	0.01	4.99	0.00	0.07	0.12
Total Assets	60.29	7.35	13.23	20.52	16.87	13.35
Current Liabilities
Accounts Payable	2.25	1.76	3.13	1.58	1.18	0.72
Accrued Liabilities	3.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	3.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	5.25	1.76	3.13	1.58	1.18	0.72
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.01	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	0.01	0.00	0.00	0.00
Total Liabilities	5.25	1.76	3.14	1.58	1.18	0.72
Stockholders' Equity
Common Stock	0.01	0.00	0.01	0.01	0.01	0.00
Retained Earnings	-75.79	-60.21	-51.80	-41.29	-32.19	-25.88
Accumulated Other Comprehensive Income	0.04	-0.01	0.01	0.00	-0.01	-0.01
Additional Paid-in Capital	130.79	65.79	61.87	60.22	47.87	38.51
Shares Outstanding	6.10	2.98	2.59	2.52	0.00	0.00
Total Stockholders' Equity	55.04	5.59	10.09	18.94	15.69	12.63
Total Liabilities & Equity	60.29	7.35	13.23	20.52	16.87	13.35